PNC Financial Services Group Inc. Sells 1,900 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

PNC Financial Services Group Inc. trimmed its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 7.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,003 shares of the company’s stock after selling 1,900 shares during the period. PNC Financial Services Group Inc.’s holdings in SPDR S&P Pharmaceuticals ETF were worth $946,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp grew its stake in shares of SPDR S&P Pharmaceuticals ETF by 146.4% during the 4th quarter. Jones Financial Companies Lllp now owns 993 shares of the company’s stock valued at $43,000 after purchasing an additional 590 shares during the period. US Bancorp DE bought a new stake in SPDR S&P Pharmaceuticals ETF during the fourth quarter valued at approximately $96,000. JPMorgan Chase & Co. grew its position in SPDR S&P Pharmaceuticals ETF by 36.2% during the third quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock valued at $197,000 after buying an additional 1,182 shares during the period. Sigma Planning Corp purchased a new stake in SPDR S&P Pharmaceuticals ETF during the fourth quarter valued at approximately $221,000. Finally, SVB Wealth LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the fourth quarter worth approximately $267,000.

SPDR S&P Pharmaceuticals ETF Price Performance

Shares of XPH stock opened at $43.71 on Tuesday. The company has a market cap of $157.36 million, a price-to-earnings ratio of 15.01 and a beta of 0.72. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.88 and a 1 year high of $48.76. The firm has a fifty day moving average price of $44.32 and a 200-day moving average price of $44.76.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.